
    
      This is a multi-center, non-interventional, single arm clinical study of the MyoVista wavECG
      for the detection of LV relaxation abnormalities. Study subjects will be drawn from patients
      who are at-risk for cardiac disease and who have been referred for 2D transthoracic
      echocardiogram.

      The study will be conducted at a minimum of three investigational sites within the United
      States.
    
  